Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 – A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data

Link to article at PubMed

Clin Infect Dis. 2021 Aug 11:ciab695. doi: 10.1093/cid/ciab695. Online ahead of print.


This post-hoc analysis of The Adaptive COVID-19 Treatment Trial-1 shows a treatment effect of remdesivir on progression to invasive mechanical ventilation (IMV) or death. Additionally, we create a risk profile that better predicts progression than baseline oxygen requirement alone. The highest risk group derives the greatest treatment effect from RDV.

PMID:34379740 | DOI:10.1093/cid/ciab695

Leave a Reply

Your email address will not be published.